POSTER: MPN-628 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs Anagrelide as Second Line Therapy in Essential Thrombocythemia
- Resource Type
- Abstract
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S196-S196 - Subject
- Language
- ISSN
- 2152-2650